Personal profile
Biography
The focus of my research is cancer evolution and heterogeneity. Cancers are made up of a heterogeneous mix of cells, each bearing a different set of mutations in its DNA. We aim to characterise groups of cells, or ‘subclones’, according to their mutational profiles and to study the interaction between subclones.
Tumours are difficult to treat because they change over time, gaining mutations that enable them to metastasise to distant organs or that result in resistance to treatment. By comparing multiple samples, we can identify those mutations that cause relapse and progression. Using genetic markers, we can also track the spread of disease, giving us insights into the mechanisms and processes involved in cancer growth and metastasis.
We have developed software packages for the purpose of studying tumour evolution and heterogeneity, including:
- The Battenberg algorithm, which identifies clonal and subclonal copy number aberrations. The Battenberg package may be downloaded from here.
- DPClust clusters mutations into subclones, identifying the Cancer Cell Fraction (CCF) and number of mutations within each subclones. DPClust may be downloaded from here.
- Octopus, a mapping-based variant caller that calls single nucleotide variants (SNVs) and small insertions and deletions (indels) using a haplotype-aware framework. Octopus may be downloaded from here.
Job vacancies
We currently have no posts available. However, we regularly advertise posts on the University of Manchester Jobs pages.
https://www.jobs.manchester.ac.uk/Home/Job
My group
The Wedge lab is made up of a talented team of researchers. To find out more about the team and the projects that we're involved in, please look at the Wedge group website.
Areas of expertise
- RC0254 Neoplasms. Tumors. Oncology (including Cancer)
- QH426 Genetics
- QA76 Computer software
Research Beacons, Institutes and Platforms
- Cancer
- Global inequalities
- Digital Futures
- Christabel Pankhurst Institute
- Manchester Cancer Research Centre
- Healthier Futures
Keywords
- cancer genomics
- tumour evolution
- Computational Biology
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
-
SDG 9 Industry, Innovation, and Infrastructure
-
SDG 10 Reduced Inequalities
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types
Everall, A., Tapinos, A., Hawari, A., Cornish, A. J., Sud, A., Chubb, D., Kinnersley, B., Frangou, A., Barquin, M., Jung, J., Church, D. N., Alexandrov, L. B., Houlston, R. S., Gruber, A. J. & Wedge, D. C., Mar 2026, In: Nature Genetics. 58, 3, p. 570-581 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Contrasting features of papillary and chromophobe renal cell carcinoma revealed by whole genome sequencing
Culliford, R., Mills, C., Chubb, D., Kinnersley, B., Sud, A., Cornish, A. J., Browning, L., Lawrence, S. E. D., Bentham, R., Frangou, A., Gruber, A. J., Litchfield, K., Wedge, D. C., Larkin, J., Turajlic, S. & Houlston, R. S., 21 Jan 2026, (E-pub ahead of print) In: Molecular Cancer Research.Research output: Contribution to journal › Article › peer-review
Open Access -
Patient-derived primary prostate cancer epithelial cultures for studying prostate cancer cell evolution under hypoxia.
Bristow, R. G., Suvac, A., Ashton, J., Rebello, R., Lyons, S., Scaramuzza, S., Mehmood, A., Hart, C. A., Swinton, M., Barton, L., Edge, G., Oliveira, P., Woodward, E., Clarke, N. W., Sachdeva, A., Sanchez Martinez, D., Jakobsdottir, M. & Wedge, D., Mar 2026, In: Journal of Clinical Oncology. 44, p. 397 1 p.Research output: Contribution to journal › Article › peer-review
-
An integrative multiparametric approach stratifies putative distinct phenotypes of blast phase chronic myelomonocytic leukemia
Gurashi, K., Wang, Y.-H., Amaral, F. M. R., Spence, K., Cant, R., Yao, C.-Y., Lin, C.-C., Wirth, C., Wedge, D. C., Montalban-Bravo, G., Colla, S., Tien, H.-F., Somervaille, T. C. P., Batta, K. & Wiseman, D. H., 18 Feb 2025, In: Cell reports. Medicine. 6, 2, 101933.Research output: Contribution to journal › Article › peer-review
Open Access -
APOBEC affects tumor evolution and age at onset of lung cancer in smokers
Zhang, T., Sang, J., Hoang, P. H., Zhao, W., Rosenbaum, J., Johnson, K. E., Klimczak, L. J., McElderry, J., Klein, A., Wirth, C., Bergstrom, E. N., Díaz-Gay, M., Vangara, R., Colon-Matos, F., Hutchinson, A., Lawrence, S. M., Cole, N., Zhu, B., Przytycka, T. M. & Shi, J. & 11 others, , 21 May 2025, In: Nature Communications. 16, 1, p. 4711Research output: Contribution to journal › Article › peer-review
-
GENERATION. Hereditary Cancer Predisposition: harnessing the ACED network to facilitate GENEtics and Risk Assessment to Tailor Interception in ONcology.
Woodward, E. (PI), Clipson, A. (CoI), Hadjidemetriou, M. (CoI), Jenkins, D. (CoI), Jorgensen, C. (CoI), Weaver, J. (CoI) & Wedge, D. (CoI)
1/09/25 → 31/08/26
Project: Research
-
DONATION: HereDitary homologous recOmbination repair deficiency (hHRD): defining and modeling the evolutioNary ecosystem to identify novel candidates for cancer eArly deTection and InterceptiOn, the paNreatic ductal adenocarcinoma (PDAC) paradigm.
Woodward, E. (PI), Jorgensen, C. (CoI), Weaver, J. (CoI) & Wedge, D. (CoI)
1/06/24 → 31/05/27
Project: Research
-
Oxford Nanopore PromethION
Ellingford, J. (PI), Adamson, A. (CoI), Banka, S. (CoI), Black, G. (CoI), Brockhurst, M. (CoI), Coyte, K. (CoI), Gifford, D. (CoI), Hayes, A. (CoI), Hubbard, S. (CoI), Lagator, M. (CoI), Mcdermott, J. (CoI), Newman, W. (CoI), Sergouniotis, P. (CoI), Sharrocks, A. (CoI) & Wedge, D. (CoI)
31/07/23 → 30/07/26
Project: Research
-
NIHR Manchester Biomedical Research Centre
Bruce, I. (PI), Lord, G. (CoI), Lennon, R. (CoI), Black, G. (CoI), Wedge, D. (CoI), Morris, A. (CoI), Hussell, T. (CoI), Sharrocks, A. (CoI), Stivaros, S. (CoI), Buch, M. (CoI), Gough, J. (CoI), Kostarelos, K. (CoI), Thistlethwaite, F. (CoI), Kadler, K. (CoI), Barton, A. (CoI), Hyrich, K. (CoI), Mcbeth, J. (CoI), O'Neill, T. (CoI), Vestbo, J. (CoI), Simpson, A. (CoI), Singh, S. (CoI), Smith, J. (CoI), Felton, T. (CoI), Murray, C. (CoI), Griffiths, C. (CoI), Cullum, N. (CoI), Rhodes, L. (CoI), Warren, R. (CoI), Paus, R. (CoI), Dumville, J. (CoI), Viros Usandizaga, A. (CoI), Keavney, B. (CoI), Tomaszewski, M. (CoI), Allan, S. (CoI), Body, R. (CoI), Cartwright, E. (CoI), Heagerty, A. (CoI), Kalra, P. (CoI), Miller, C. (CoI), Rutter, M. (CoI), Smith, C. (CoI), Trafford, A. (CoI), Evans, D. (CoI), Davidson, E. (CoI), Crosbie, P. (CoI), Harvie, M. (CoI), Howell, S. (CoI), Renehan, A. (CoI), Dive, C. (CoI), Blackhall, F. (CoI), Landers, D. (CoI), Krebs, M. (CoI), Cook, N. (CoI), Clarke, R. (CoI), Taylor, S. (CoI), Jorgensen, C. (CoI), Lorigan, P. (CoI), Jayson, G. (CoI), Valle, J. (CoI), Mccabe, M. (CoI), Armstrong, A. (CoI), Freitas, A. (CoI), Illidge, T. (CoI), Choudhury, A. (CoI), Hoskin, P. (CoI), West, C. (CoI), Van Herk, M. (CoI), Faivre-Finn, C. (CoI), Bristow, R. (CoI), Kirkby, K. (CoI), Birtle, A. (CoI), Mackay, R. (CoI), Radford, J. (CoI), Linton, K. (CoI), Higham, C. (CoI), Munro, K. (CoI), Plack, C. (CoI), Arden Armitage, C. (CoI), Bruce, I. (CoI), Moore, D. (CoI), Saunders, G. (CoI), Stone, M. (CoI), Haddock, G. (CoI), Lewis, S. (CoI), Elliott, R. (CoI), Green, J. (CoI), Lovell, K. (CoI), Morrison, A. (CoI), Shaw, J. (CoI), Bucci, S. (CoI), Ainsworth, J. (CoI), Webb, R. (CoI), Newman, W. (CoI), Banka, S. (CoI), Clayton-Smith, J. (CoI), Payne, K. (CoI), Moldovan, R. (CoI), Wynn, R. (CoI) & Jones, S. (CoI)
1/12/22 → 30/11/27
Project: Research
-
Data-driven cancer genome interpretation for personalised cancer treatment (PROJECT)
Lindsay, C. (PI), Blackhall, F. (CoI) & Wedge, D. (CoI)
1/11/22 → 31/10/27
Project: Research
Prizes
Impacts
-
Aiming to create a risk model for radiation-associated malignant progression in familial NF2
Paterson, C. (Corresponding participant), Smith, M. (Participant) & Wedge, D. (Participant)
Impact: Health and wellbeing
-
Seeking improved treatments for patients with non-small-cell lung cancer & KRAS G12D mutation
Lindsay, C. (Corresponding participant), Blackhall, F. (Participant) & Wedge, D. (Participant)
Impact: Health and wellbeing
Press/Media
-
UK cancer scientists uncover genetic clues as to what drives tumour growth
30/03/26
1 Media contribution
Press/Media: Research
-
Artificial Intelligence reveals prostate cancer is not just one disease
29/02/24 → 1/03/24
5 items of Media coverage
Press/Media: Research